Showing results (761-770 of 1,340) with videos related to
Sort By:
Pageof 134
Neuro-Oncology Advances|December 13, 2021
Multiparametric radiomic tissue signature and machine learning for distinguishing radiation necrosis from tumor progression after stereotactic radiosurgeryXuguang Chen, Vishwa S Parekh, Luke Peng, et al.Neuro-Oncology Advances|December 13, 2021
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytesMatteo Simonelli, Pasquale Persico, Arianna Capucetti, et al.Neuro-Oncology Advances|November 5, 2021
Association between height and the risk of primary brain malignancy in adults: a nationwide population-based cohort studyStephen Ahn, Kyungdo Han, Jung Eun Lee, et al.Neuro-Oncology Advances|September 8, 2022
Identifying clinically applicable machine learning algorithms for glioma segmentation: recent advances and discoveriesNiklas Tillmanns, Avery E Lum, Gabriel Cassinelli, et al.Neuro-Oncology Advances|January 7, 2022
Phase I study using crenolanib to target PDGFR kinase in children and young adults with newly diagnosed DIPG or recurrent high-grade glioma, including DIPGChristopher L Tinkle, Alberto Broniscer, Jason Chiang, et al.Neuro-Oncology Advances|September 2, 2025
Glutamate to GABA ratio is elevated in patients with IDH-mutant lower-grade gliomas and seizuresRiccardo Pascuzzo, Roberta Rudà, Peter B Barker, et al.Neuro-Oncology Advances|September 3, 2025
Combined inhibition of SHP2 overcomes adaptive resistance to type 1 BRAF inhibitors in BRAF V600E-driven high-grade gliomaAbiola A Ayanlaja, Michael Chang, Kriti Lalwani, et al.Neuro-Oncology Advances|May 20, 2021
Receptor-driven invasion profiles in diffuse intrinsic pontine gliomaAnju Karki, Noah E Berlow, Jin-Ah Kim, et al.Neuro-Oncology Advances|August 19, 2021
A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade gliomaKendall L Hughes, Christen M O'Neal, Bethany J Andrews, et al.Neuro-Oncology Advances|August 4, 2021
Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentationHuy Gia Vuong, Tam N M Ngo, Ian F DunnPageof 134